Brief: Nuvectis Pharma Inc Says As Of June 30 Co Has About $24.5 Mln Of Cash And Cash Equivalents
July 3 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA INC SAYS AS OF JUNE 30, CO HAS ABOUT $24.5
MILLION OF CASH AND CASH EQUIVALENTS,
* NUVECTIS PHARMA - ESTIMATES CURRENT CASH AND CASH
EQUIVALENTS
POSITION IS SUFFICIENT TO FUND PLANNED OPERATIONS INTO FIRST
HALF OF 2025
Further company coverage: NVCT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin